Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Seagate Technology Holdings PLC (STX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Seagate Technology Holdings PLC — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Seagate Technology Holdings PLC trades at $689.7 (market cap $169.91B). The key difference: Seagate Technology Holdings PLC is far larger — about 32.8× Oruka Therapeutics Inc. Common Stock's market cap, and Seagate Technology Holdings PLC pays a 0.4% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Seagate Technology Holdings PLC for 41 Days on average.
| ORKA | STX | |
|---|---|---|
Market Cap | $5.18B | $169.91B |
Volume | 490,798 | 6,791,866 |
Sector | Health | Technology |
52-Week High | $113.08 | $1.09K |
52-Week Low | $26.19 | $214.40 |
Typical Hold Time | 0 Days | 41 Days |
Enterprise Value | $4.31B | $172.06B |
Dividend Yield | — | 0.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Seagate Technology (STX) trades at $713.54, down 5.27% amid concerns over increased competition from Toshiba's AI storage expansion plans. The stock shows strong profitability with a 26.11% net margin and has beaten EPS estimates for three consecutive quarters. Technical indicators are bearish, with the price below key support levels, while analyst consensus remains positive with a $1,130 price target.
Outlook: Long-term growth is supported by AI-driven storage demand and robust earnings, but near-term risks include competitive pressures and high valuation multiples. The stock presents a contrarian opportunity if competitive fears ease, though volatility may persist.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Seagate Technology Holdings PLC
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →
